Skip to content

Clinical study of Bacterial Lysates Capsules in preventing postoperative recurrence of chronic rinosinusitis

Clinical study of Bacterial Lysates Capsules in preventing postoperative recurrence of chronic rinosinusitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075072
Enrollment
Unknown
Registered
2023-08-24
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis

Interventions

Experimental group:Regular therapy+ Bacterial Lysates Capsules

Sponsors

The Third Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? 18-70 years old, gender unlimited; ? The diagnostic criteria for chronic sinusitis are strictly according to the 2012 European Society of Allergy and Clinical Immunology(European Academy of Allergy and Clinical Immunology, EAACI) published diagnostic guidelines for chronic rhinosinusitis, the main symptoms: nasal congestion, sticky purulent nasal discharge; Secondary symptoms: head and face swelling pain, decreased or loss of smell, based on the above two or two related symptoms, one of the main symptoms of nasal congestion and mucopurulent nasal discharge must be one, and through sinus CT, nasal endoscopy and other examinations confirmed that the patient has unilateral or bilateral middle nasal tract polyps; Chronic sinusitis and/or concomitant nasal polyps; Surgery is needed; ? Both patients received or did not receive drug therapy; ? No previous immunotherapy (desensitization, bacterial lysate, etc.); ? No major neurological disease, serious systemic disease, family genetic history, major mental illness.

Exclusion criteria

Exclusion criteria: ? Patients who are allergic to the composition of Bacterial Lysates Capsules; ? Acute intestinal infection, upper respiratory tract infection, asthma or other serious systemic disease; ? Other nasal diseases such as Antrochoanal Polyps, cystic fibrosis, primary ciliary immobile disease, fungal rhinitis, allergic rhinitis or inverted papilloma; ? Do not agree to join the experiment,or have a plan to move out or go out within 3 months.

Design outcomes

Primary

MeasureTime frame
Lund-Kennedy score;Visual analogue scale, VAS;SNOT-22;

Countries

China

Contacts

Public ContactYang Qintai

The Third Affiliated Hospital, Sun Yat-sen University

yang.qt@163.com+86 189 2210 3352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026